Back to
Ensign Peak Advisors, Inc
VKTX
Showing 8 of 14 quarters
Position history for
Ensign Peak Advisors, Inc's holdings in Viking Therapeutics, Inc.
Yes. Ensign Peak Advisors holds 7,789 shares of VKTX (Viking Therapeutics), worth $303,849, as of its Q2 2026 13F filing. It increased the position by 850 shares (+12.3%) from Q1 2026. Ensign Peak Advisors has held VKTX since Q1 2023, across 14 quarterly 13F filings.
Current Value
$303,849
Current Shares
7,789
Total Value Change
-$28.3M
Total Shares Change
-444,222
Quarter-by-Quarter History